Barclays Maintains Overweight on MasTec, Lowers Price Target to $320
Barclays analyst Adam Seiden maintains MasTec (NYSE:MTZ) with a Overweight and lowers the price target from $340 to $320.
Share
Why It Matters
An expert analyst still likes MasTec but thinks its stock price might be a bit lower than before. This tells you the company is still doing well, just maybe worth slightly less money right now.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.